SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-063511
Filing Date
2022-05-20
Accepted
2022-05-20 17:53:33
Documents
1
Period of Report
2022-05-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2215971-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2215971-3_4seq1.xml 4 3364
  Complete submission text file 0001104659-22-063511.txt   4724
Mailing Address C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730
Business Address
PETERS WILLIAM J (Reporting) CIK: 0001263136 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36509 | Film No.: 22949010

Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences